Skip to content

Our 2030 ambition

Then, our ambition for 2030 is to be:

An innovative and patient-driven company with a rich pipeline
A resilient, growing and highly profitable company balanced on three pillars: oncology and neuroscience & immuno-inflammation, cardiometabolism and venous disease, and Generics
A company with a measurable positive social impact
An attractive company, with proud and passionate employees

To reach this ambition, we rely on a strategy based on the following axes:

  • create a significant positive social impact for a sustainable world;
  • to be an innovative player in oncology, neuroscience and immuno-inflammation;
  • to be an ever-recognized leader in cardio metabolism and venous disease;
  • fuel organic profitable growth for our Generics;
  • perform with a reshaped industrial operations value chain;
  • be an agile organization and a digital performer;
  • be all proud and passionate about our Vocation.

Our Vocation

Committed to therapeutic progress to serve patient needs

Photo d'un médecin avec son patient

Our Values

Servier's Values

Dare to innovate

Servier's Values


Servier's Values

Grow by sharing

Servier's Values

Commit to succeed

Photo of a girl in consultation

Our Vision

Founded to serve health, our Group aspires to make a meaningful social impact for patients and for a sustainable world.